Feb 29 2024 34 mins 3
Reducing the burden of type 1 diabetes
Despite many recent advances in its management, type 1 diabetes remains a burden for those living with the condition.
Prof Chantal Mathieu explains the progress being made with disease-modifying therapy for type 1 diabetes and how it has the potential to transform the current treatment landscape.
For more on how Springer Medicine can tailor medical education to meet your needs, head to SpringerMedicine.com and register for updates.
